Calendar Bio-Techne Corporation

Equities

TECH

US09073M1045

Market Closed - Nasdaq 04:00:00 2024-02-27 pm EST 5-day change 1st Jan Change
73.21 USD +1.81% Intraday chart for Bio-Techne Corporation +4.09% -5.12%

Chart calendar Bio-Techne Corporation

5bed8813f8.KdD9DJ1OUo1huJk4CjV3MA8OF6eVYCWYQr1y6ICVvfc.T7SpPvMGFulY67RwQnMYeU50be2sC3fPNPw5xdf51qRBkbZN-SM8-lbrqQ~2183b111b7358defa95cb69bbf5a06d3

Upcoming events on Bio-Techne Corporation

2024-04-30 Q3 2024 Earnings Release (Projected)
2024-08-05 Q4 2024 Earnings Release (Projected)
2024-10-28 Q1 2025 Earnings Release (Projected)
2025-02-03 Q2 2025 Earnings Release (Projected)

Past events on Bio-Techne Corporation

2024-02-08 Ex-dividend day
2024-02-04 Genome Biology and Technology General Meeting
2024-02-01 09:00 am Q2 2024 Earnings Call
2024-01-31 Q2 2024 Earnings Release
2024-01-19 10:00 am Phacilitate Advanced Therapies Conference
2024-01-18 08:00 am Phacilitate Advanced Therapies Conference - Roundtable Talk
2024-01-10 12:00 pm JPMorgan Healthcare Conference
2023-11-29 02:10 pm Evercore ISI HealthCONx Conference
2023-11-15 03:00 pm Stephens Investment Conference
2023-11-15 02:00 pm Association for Molecular Pathology Meeting
2023-11-15 08:35 am Stifel Healthcare Conference
2023-11-08 Ex-dividend day
2023-11-04 07:00 pm Society for Immunotherapy of Cancer Meeting - Poster number: 222D
2023-11-04 11:55 am Society for Immunotherapy of Cancer Meeting - Poster number: 222D
2023-11-04 11:55 am Society for Immunotherapy of Cancer Meeting - Poster number: 102
2023-11-03 05:10 pm Society for Immunotherapy of Cancer Meeting - Poster number: 71
2023-11-03 05:10 pm Society for Immunotherapy of Cancer Meeting - Poster number: 107
2023-11-03 05:10 pm Society for Immunotherapy of Cancer Meeting - Poster number: 65
2023-11-03 05:10 pm Society for Immunotherapy of Cancer Meeting - Poster number: 1475
2023-11-03 02:00 pm Society for Immunotherapy of Cancer Meeting - Poster number: 71

Past dividends on Bio-Techne Corporation

2024-02-08 Quarterly 0.08 USD
2023-11-08 Quarterly 0.08 USD
2023-08-16 Quarterly 0.08 USD
2023-05-11 Quarterly 0.08 USD
2023-02-09 Quarterly 0.08 USD
2022-11-09 Quarterly 0.32 USD
2022-08-11 Quarterly 0.32 USD
2022-05-12 Quarterly 0.32 USD
2022-02-09 Quarterly 0.32 USD
2021-11-09 Quarterly 0.32 USD

Annual results

Fiscal PeriodJune 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
714
722
-1.1%
739
728
1.46%
931
916
1.59%
1 106
1 108
-0.24%
1 137
1 143
-0.51%

1 148

EBITDA
Million USD
Released
Forecast
Spread
264
280
-5.54%
268
254
5.36%
386
378
1.97%
449
449
0.14%
441
446
-1.04%

401

EBIT
Million USD
Released
Forecast
Spread
245
248
-1.47%
246
233
5.66%
362
354
2.29%
421
424
-0.67%
410
412
-0.53%

367

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
112
130
-13.57%
276
230
19.97%
148
200
-25.75%
301
294
2.64%
339
331
2.36%

200

Net income
Million USD
Released
Forecast
Spread
96,1
110
-12.32%
229
181
26.37%
140
169
-17.15%
272
270
0.74%
285
274
4.06%

177

EPS
USD
Released
Forecast
Spread
0,62
0,71
-12.41%
1,46
1,15
26.58%
0,87
1,05
-17.26%
1,66
1,64
1.22%
1,76
1,69
4.05%

1,10

Announcement Date06/08/1904/08/2005/08/2104/08/2208/08/23-

Quarterly results

Fiscal PeriodJune 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3
Net sales
Million USD
Released
Forecast
Spread
269
267
1.01%
290
279
3.98%
288
287
0.41%
270
282
-4.29%
272
290
-6.26%
294
299
-1.48%
301
308
-2.26%
277
288
-3.72%
273
278
-1.85%

293


306


293


298


321

EBITDA
Million USD
Released
Forecast
Spread
110
104
5.21%
122
116
4.59%
114
113
1.34%
101
102
-1.04%
104
109
-4.49%
116
117
-0.9%
120
122
-1.32%
95,6
99,1
-3.51%
93,2
98,1
-4.92%

103


112


103


105


119

EBIT
Million USD
Released
Forecast
Spread
103
97,1
5.87%
115
107
6.79%
107
111
-3.64%
93,2
97,5
-4.47%
96,5
103
-5.98%
109
110
-1.33%
112
114
-1.51%
86,9
91,9
-5.41%
81,9
87,2
-6.03%

94,2


103


95,4


98,1


110

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
86,2
61,6
39.87%
68,8
72,5
-5.1%
79,1
77,2
2.4%
104
64,4
61.11%
66,4
73,9
-10.12%
80,2
77,2
3.92%
88,3
80,5
9.71%
49,6
61,1
-18.87%
33,4
53,7
-37.86%

54,1


62,9


57,1


63,7


70,9

Net income
Million USD
Released
Forecast
Spread
80,2
49,8
60.89%
60,7
57,6
5.4%
61,5
62,6
-1.79%
89,6
52,8
69.62%
50,0
55,4
-9.73%
70,2
63,1
11.3%
75,5
64,0
17.92%
51,0
47,1
8.25%
27,5
43,3
-36.5%

45,4


53,3


46,8


52,1


58,9

EPS
USD
Released
Forecast
Spread
0,49
0,30
60.55%
0,37
0,35
5.97%
0,38
0,38
-0.66%
0,55
0,32
70.22%
0,31
0,34
-9.05%
0,43
0,39
10.26%
0,47
0,40
18.49%
0,31
0,29
6.28%
0,17
0,27
-35.85%

0,28


0,33


0,29


0,33


0,37

Announcement Date01/02/2204/05/2204/08/2201/11/2202/02/2303/05/2308/08/2331/10/2301/02/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

-40% Limited-time offer: Our subscriptions help you unlock the best investment opportunities.
SIGN UP NOW